Lenz Robert A.

CIK 00019929083 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001992908

Recent Transactions

18 trades

Exercise/Conversion
NovaBridge Biosciences$NBP
Ordinary Shares
2026-08-22+17,218→ 17,218 total
Exercise/Conversion
NovaBridge Biosciences$NBP
Restricted Share Units
2026-08-22−7,486→ 14,974 total
Award
LB PHARMACEUTICALS INC$LBRX
Stock Option (Right to Buy)
2026-06-03+12,500→ 12,500 total
Award
LB PHARMACEUTICALS INC$LBRX
Stock Option (Right to Buy)
2026-03-06+20,000→ 20,000 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2025-02-18$1.67/sh−5,614→ 309,092 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−100,000→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+100,000→ 100,000 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−502,934→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+502,934→ 502,934 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-10-10$15.09/sh−8,260→ 314,706 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-10-09$15.01/sh−5,563→ 322,966 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-09-18$12.09/sh−10,676→ 328,529 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-09-17$11.81/sh−30,788→ 339,205 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-09-12$11.43/sh−32,948→ 369,993 total
Award
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-02-14+50,000→ 402,941 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2024-02-14+100,000→ 100,000 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2023-09-14+502,934→ 502,934 total
Award
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-14+352,941→ 352,941 total

Companies

Recent Filings

Address

C/O NOVABRIDGE BIOSCIENCES 2440 RESEARCH BOULEVARD, SUITE 400

ROCKVILLE, MD, 20850

View on SEC.gov